147 related articles for article (PubMed ID: 25854294)
41. Time trends in systemic thrombolysis in a large hospital-based stroke registry.
Singer OC; Hamann GF; Misselwitz B; Steinmetz H; Foerch C;
Cerebrovasc Dis; 2012; 33(4):316-21. PubMed ID: 22343969
[TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness estimate of prehospital thrombolysis: results of the PHANTOM-S study.
Gyrd-Hansen D; Olsen KR; Bollweg K; Kronborg C; Ebinger M; Audebert HJ
Neurology; 2015 Mar; 84(11):1090-7. PubMed ID: 25672925
[TBL] [Abstract][Full Text] [Related]
43. Thrombolysis for acute ischemic stroke in Joint Commission-certified and -noncertified hospitals in Michigan.
Rajamani K; Millis S; Watson S; Mada F; Salowich-Palm L; Hinton S; Chaturvedi S
J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):49-54. PubMed ID: 21852156
[TBL] [Abstract][Full Text] [Related]
44. Hospital-based financial analysis of endovascular therapy and intravenous thrombolysis for large vessel acute ischemic strokes: the 'bottom line'.
Rai AT; Evans K
J Neurointerv Surg; 2015 Feb; 7(2):150-6. PubMed ID: 24476964
[TBL] [Abstract][Full Text] [Related]
45. Quality of acute ischemic stroke care in Thailand: a prospective multicenter countrywide cohort study.
Nilanont Y; Nidhinandana S; Suwanwela NC; Hanchaiphiboolkul S; Pimpak T; Tatsanavivat P; Saposnik G; Poungvarin N;
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):213-9. PubMed ID: 23305673
[TBL] [Abstract][Full Text] [Related]
46. Cost of acute ischemic and hemorrhagic stroke in Turkey.
Asil T; Celik Y; Sut N; Celik AD; Balci K; Yilmaz A; Karaduman F
Clin Neurol Neurosurg; 2011 Feb; 113(2):111-4. PubMed ID: 21036465
[TBL] [Abstract][Full Text] [Related]
47. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
Yan X; Hu HT; Liu S; Sun YH; Gao X
Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
[TBL] [Abstract][Full Text] [Related]
48. Role of tissue plasminogen activator in acute ischemic stroke.
Hatcher MA; Starr JA
Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
[TBL] [Abstract][Full Text] [Related]
49. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.
Ciccone A; Valvassori L; Nichelatti M;
Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814
[TBL] [Abstract][Full Text] [Related]
50. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
[TBL] [Abstract][Full Text] [Related]
51. Susceptibility-weighted imaging for cerebral microbleed detection in super-acute ischemic stroke patients treated with intravenous thrombolysis.
Bai Q; Zhao Z; Sui H; Xie X; Chen J; Yang J; Zhang L
Neurol Res; 2013 Jul; 35(6):586-93. PubMed ID: 23561793
[TBL] [Abstract][Full Text] [Related]
52. Cost avoidance associated with optimal stroke care in Canada.
Krueger H; Lindsay P; Cote R; Kapral MK; Kaczorowski J; Hill MD
Stroke; 2012 Aug; 43(8):2198-206. PubMed ID: 22627985
[TBL] [Abstract][Full Text] [Related]
53. Cost-effectiveness of optimizing acute stroke care services for thrombolysis.
Penaloza-Ramos MC; Sheppard JP; Jowett S; Barton P; Mant J; Quinn T; Mellor RM; Sims D; Sandler D; McManus RJ;
Stroke; 2014 Feb; 45(2):553-62. PubMed ID: 24385272
[TBL] [Abstract][Full Text] [Related]
54. Modelling the efficiency of local versus central provision of intravenous thrombolysis after acute ischemic stroke.
McMeekin P; Gray J; Ford GA; Rodgers H; Price CI
Stroke; 2013 Nov; 44(11):3114-9. PubMed ID: 23982716
[TBL] [Abstract][Full Text] [Related]
55. Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke.
Samsa GP; Reutter RA; Parmigiani G; Ancukiewicz M; Abrahamse P; Lipscomb J; Matchar DB
J Clin Epidemiol; 1999 Mar; 52(3):259-71. PubMed ID: 10210244
[TBL] [Abstract][Full Text] [Related]
56. Financial Burden of Stroke Reflected in a Pilot Center for the Implementation of Thrombolysis.
Uivarosan D; Bungau S; Tit DM; Moisa C; Fratila O; Rus M; Bratu OG; Diaconu CC; Pantis C
Medicina (Kaunas); 2020 Jan; 56(2):. PubMed ID: 32013001
[TBL] [Abstract][Full Text] [Related]
57. Centralising and optimising decentralised stroke care systems: a simulation study on short-term costs and effects.
Lahr MM; van der Zee DJ; Luijckx GJ; Vroomen PC; Buskens E
BMC Med Res Methodol; 2017 Jan; 17(1):5. PubMed ID: 28073360
[TBL] [Abstract][Full Text] [Related]
58. The cost of first-ever stroke in Valle d'Aosta, Italy: linking clinical registries and administrative data.
Bottacchi E; Corso G; Tosi P; Morosini MV; De Filippis G; Santoni L; Furneri G; Negrini C
BMC Health Serv Res; 2012 Oct; 12():372. PubMed ID: 23110322
[TBL] [Abstract][Full Text] [Related]
59. Regional variation in acute stroke care organisation.
Muñoz Venturelli P; Robinson T; Lavados PM; Olavarría VV; Arima H; Billot L; Hackett ML; Lim JY; Middleton S; Pontes-Neto O; Peng B; Cui L; Song L; Mead G; Watkins C; Lin RT; Lee TH; Pandian J; de Silva HA; Anderson CS;
J Neurol Sci; 2016 Dec; 371():126-130. PubMed ID: 27871433
[TBL] [Abstract][Full Text] [Related]
60. Estimating the long-term costs of ischemic and hemorrhagic stroke for Australia: new evidence derived from the North East Melbourne Stroke Incidence Study (NEMESIS).
Cadilhac DA; Carter R; Thrift AG; Dewey HM
Stroke; 2009 Mar; 40(3):915-21. PubMed ID: 19182091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
